124 related articles for article (PubMed ID: 3880086)
1. Cyclosporine therapy for uveitis: long-term followup.
Nussenblatt RB; Palestine AG; Chan CC
J Ocul Pharmacol; 1985; 1(4):369-82. PubMed ID: 3880086
[TBL] [Abstract][Full Text] [Related]
2. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
Whitcup SM; Salvo EC; Nussenblatt RB
Am J Ophthalmol; 1994 Jul; 118(1):39-45. PubMed ID: 8023874
[TBL] [Abstract][Full Text] [Related]
3. Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
Ozdal PC; Ortaç S; Taskintuna I; Firat E
Doc Ophthalmol; 2002 Nov; 105(3):301-12. PubMed ID: 12539855
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of cyclosporin therapy for Behçet's disease.
Nussenblatt RB; Palestine AG; Chan CC; Mochizuki M; Yancey K
Arthritis Rheum; 1985 Jun; 28(6):671-9. PubMed ID: 4004976
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with chronic uveitis affecting the posterior pole treated with combination cyclosporine and ketoconazole.
Ramadan AM; Nussenblatt RB; de Smet MD
Ophthalmology; 1997 Apr; 104(4):706-11. PubMed ID: 9111267
[TBL] [Abstract][Full Text] [Related]
6. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
Vitale AT; Rodriguez A; Foster CS
Ophthalmology; 1996 Mar; 103(3):365-73; discussion 373-4. PubMed ID: 8600411
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis.
Nussenblatt RB; Palestine AG; Chan CC; Stevens G; Mellow SD; Green SB
Am J Ophthalmol; 1991 Aug; 112(2):138-46. PubMed ID: 1867297
[TBL] [Abstract][Full Text] [Related]
8. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
9. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A therapy in refractory non-infectious childhood uveitis.
Kilmartin DJ; Forrester JV; Dick AD
Br J Ophthalmol; 1998 Jul; 82(7):737-42. PubMed ID: 9924362
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience.
Miserocchi E; Baltatzis S; Ekong A; Roque M; Foster CS
Ophthalmology; 2002 Jan; 109(1):137-42. PubMed ID: 11772593
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
[TBL] [Abstract][Full Text] [Related]
14. Treatment of endogenous uveitis with cyclosporine A.
BenEzra D; Cohen E; Rakotomalala M; de Courten C; Harris W; Chajek T; Friedman G; Matamoros N
Transplant Proc; 1988 Jun; 20(3 Suppl 4):122-7. PubMed ID: 3381266
[TBL] [Abstract][Full Text] [Related]
15. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
[TBL] [Abstract][Full Text] [Related]
16. Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
Heiligenhaus A; Zurek-Imhoff B; Roesel M; Hennig M; Rammrath D; Heinz C
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):143-52. PubMed ID: 23073842
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA).
Nguyen QD; Merrill PT; Clark WL; Banker AS; Fardeau C; Franco P; LeHoang P; Ohno S; Rathinam SR; Thurau S; Abraham A; Wilson L; Yang Y; Shams N;
Ophthalmology; 2016 Nov; 123(11):2413-2423. PubMed ID: 27692526
[TBL] [Abstract][Full Text] [Related]
18. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
Nguyen QD; Merrill PT; Jaffe GJ; Dick AD; Kurup SK; Sheppard J; Schlaen A; Pavesio C; Cimino L; Van Calster J; Camez AA; Kwatra NV; Song AP; Kron M; Tari S; Brézin AP
Lancet; 2016 Sep; 388(10050):1183-92. PubMed ID: 27542302
[TBL] [Abstract][Full Text] [Related]
19. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine.
Sloper CM; Powell RJ; Dua HS
Ophthalmology; 1999 Apr; 106(4):723-8. PubMed ID: 10201592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
